Denali Therapeutics (DNLI) EBIT Margin (QoQ) (2018 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Denali Therapeutics | 3.82 Bn | 3.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -903,942.00 |
| Jun 30, 2023 | 40,176.00 |
| Mar 31, 2023 | 70,964.00 |
| Dec 31, 2022 | 5.74 Mn |
| Sep 30, 2022 | -5.83 Mn |
| Jun 30, 2022 | 4,077.00 |
| Mar 31, 2022 | 45,848.00 |
| Dec 31, 2021 | 100,327.00 |
| Sep 30, 2021 | -120,743.00 |
| Jun 30, 2021 | 712.16 Mn |
| Mar 31, 2021 | -712.21 Mn |
| Dec 31, 2020 | 120.24 Mn |
| Sep 30, 2020 | -120.13 Mn |
| Jun 30, 2020 | 11.43 Mn |
| Mar 31, 2020 | -11.41 Mn |
| Dec 31, 2019 | 5.10 Mn |
| Sep 30, 2019 | 1.12 Mn |
| Jun 30, 2019 | -6.24 Mn |
| Mar 31, 2019 | -107,038.00 |
| Dec 31, 2018 | 323,639.00 |
| Sep 30, 2018 | 30,501.00 |
| Jun 30, 2018 | 53,493.00 |